Semin Plast Surg 2014; 28(02): 104-110
DOI: 10.1055/s-0034-1376265
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Vascular Anomalies and Airway Concerns

Caroline Clarke
1   Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas
,
Edward I. Lee
1   Division of Plastic Surgery, Baylor College of Medicine, Houston, Texas
,
Joseph Edmonds Jr.
2   Department of Otolaryngology – Head & Neck Surgery, Baylor College of Medicine, Houston, Texas
› Author Affiliations
Further Information

Publication History

Publication Date:
31 May 2014 (online)

Abstract

Vascular anomalies, both tumors and malformations, can occur anywhere in the body, including the airway, often without any external manifestations. However, vascular anomalies involving the airway deserve special consideration as proper recognition and management can be lifesaving. In this article, the authors discuss vascular anomalies as they pertains to the airway, focusing on proper diagnosis, diagnostic modalities, and therapeutic options.

 
  • References

  • 1 Mulliken JB, Glowacki J. Classification of pediatric vascular lesions. Plast Reconstr Surg 1982; 70 (1) 120-121
  • 2 Chen TS, Eichenfield LF, Friedlander SF. Infantile hemangiomas: an update on pathogenesis and therapy. Pediatrics 2013; 131 (1) 99-108
  • 3 Burrows PE, Laor T, Paltiel H, Robertson RL. Diagnostic imaging in the evaluation of vascular birthmarks. Dermatol Clin 1998; 16 (3) 455-488
  • 4 Edmonds JL . Hemangioma and vascular malformations. In: Lalwani AK, ed. Current Diagnosis and Treatment in Otolaryngology—Head and Neck Surgery. 3 rd ed. New York: McGraw-Hill; 2012: 213-223
  • 5 Metry D, Heyer G, Hess C , et al; PHACE Syndrome Research Conference. Consensus statement on diagnostic criteria for PHACE syndrome. Pediatrics 2009; 124 (5) 1447-1456
  • 6 Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol 1996; 132 (3) 307-311
  • 7 Drolet BA, Frommelt PC, Chamlin SL , et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics 2013; 131 (1) 128-140
  • 8 O-Lee TJ, Messner A. Subglottic hemangioma. Otolaryngol Clin North Am 2008; 41 (5) 903-911, viii–ix viii–ix.
  • 9 Izadpanah A, Izadpanah A, Kanevsky J, Belzile E, Schwarz K. Propranolol versus corticosteroids in the treatment of infantile hemangioma: a systematic review and meta-analysis. Plast Reconstr Surg 2013; 131 (3) 601-613
  • 10 Javia LR, Zur KB, Jacobs IN. Evolving treatments in the management of laryngotracheal hemangiomas: will propranolol supplant steroids and surgery?. Int J Pediatr Otorhinolaryngol 2011; 75 (11) 1450-1454
  • 11 Perkins JA, Chen BS, Saltzman B, Manning SC, Parikh SR. Propranolol therapy for reducing the number of nasal infantile hemangioma invasive procedures. JAMA Otolaryngol Head Neck Surg 2014; 140 (3) 220-227 [Epub ahead of print]
  • 12 Jafarzadeh H, Sanatkhani M, Mohtasham N. Oral pyogenic granuloma: a review. J Oral Sci 2006; 48 (4) 167-175
  • 13 Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69 (3) 412-422
  • 14 Breugem CC, van Der Horst CM, Hennekam RC. Progress toward understanding vascular malformations. Plast Reconstr Surg 2001; 107 (6) 1509-1523
  • 15 Marler JJ, Fishman SJ, Upton J , et al. Prenatal diagnosis of vascular anomalies. J Pediatr Surg 2002; 37 (3) 318-326
  • 16 Wong GB, Mulliken JB, Benacerraf BR. Prenatal sonographic diagnosis of major craniofacial anomalies. Plast Reconstr Surg 2001; 108 (5) 1316-1333
  • 17 Colletti G, Valassina D, Bertossi D, Melchiorre F, Vercellio G, Brusati R. Contemporary management of vascular malformations. J Oral Maxillofac Surg 2014; 72 (3) 510-528
  • 18 Padwa BL, Hayward PG, Ferraro NF, Mulliken JB. Cervicofacial lymphatic malformation: clinical course, surgical intervention, and pathogenesis of skeletal hypertrophy. Plast Reconstr Surg 1995; 95 (6) 951-960
  • 19 Shiels II WE, Kenney BD, Caniano DA, Besner GE. Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg 2008; 43 (1) 136-139 , discussion 140
  • 20 Smith MC, Zimmerman MB, Burke DK, Bauman NM, Sato Y, Smith RJ ; OK-432 Collaborative Study Group. Efficacy and safety of OK-432 immunotherapy of lymphatic malformations. Laryngoscope 2009; 119 (1) 107-115
  • 21 Burrows PE, Mitri RK, Alomari A , et al. Percutaneous sclerotherapy of lymphatic malformations with doxycycline. Lymphat Res Biol 2008; 6 (3-4) 209-216
  • 22 Berenguer B, Burrows PE, Zurakowski D, Mulliken JB. Sclerotherapy of craniofacial venous malformations: complications and results. Plast Reconstr Surg 1999; 104 (1) 1-11 , discussion 12–15
  • 23 Kohout MP, Hansen M, Pribaz JJ, Mulliken JB. Arteriovenous malformations of the head and neck: natural history and management. Plast Reconstr Surg 1998; 102 (3) 643-654
  • 24 Greene AK, Orbach DB. Management of arteriovenous malformations. Clin Plast Surg 2011; 38 (1) 95-106
  • 25 Lee BB, Do YS, Yakes W, Kim DI, Mattassi R, Hyon WS. Management of arteriovenous malformations: a multidisciplinary approach. J Vasc Surg 2004; 39 (3) 590-600